| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.1 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.2 |